Clinical Trials Logo

Clinical Trial Summary

Laboratory monitoring of patients included serial measurement of complete blood cell count, liver function tests, coagulation profile, and renal function tests.

ICU management during conduction of the research study included the following:

Control of convulsions using magensium sulphate. Control of blood pressure Diastolic blood pressure above 110 mmHg, nifedipine was administered.A plasma volume expansion with saline was used in all women to maintain sufficient intravascular volume. Delivery was performed immediately after hemodynamic stabilization and clinical control of general condition .


Clinical Trial Description

Laboratory monitoring of patients included serial measurement of complete blood cell count, liver function tests, coagulation profile, and renal function tests.

ICU management included the following:

Control of convulsions by Loading dose of magensium sulphate (4-6g I.V), given over 20 minutes in 100 ml of dextrose then Maintenance dose (4-6g) magensium sulphate in 500 cc dextrose given over 8 hours using continuous IV drip.Control of blood pressure if Diastolic blood pressure above 110 mmHg, nifedipine was administered. Delivery was performed immediately after hemodynamic stabilization and clinical control of general condition .Termination of gestation decision was based on the the presence of maternal complications, fetal distress.After delivery the patient is retrurned to ICU under clinical and careful observation of the following:Heart rate, blood pressure,every 15 min,Temperature and respiratory rate ,evey 4 hours. Duration of admission in the ICU was assessed ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03412552
Study type Observational
Source Cairo University
Contact
Status Completed
Phase N/A
Start date October 1, 2015
Completion date December 30, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05999851 - Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy N/A
Recruiting NCT05687344 - Intensive Postpartum Antihypertensive Treatment Phase 3
Recruiting NCT02020174 - The Preeclampsia Registry
Recruiting NCT06377878 - The Preeclampsia Registry
Recruiting NCT05995106 - mHealth for Hypertensive Disorder of Pregnancy N/A
Completed NCT03309826 - Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy N/A
Completed NCT05631067 - Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality N/A
Completed NCT03728790 - Remote BP Monitoring in the PP Period N/A
Recruiting NCT05089175 - The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
Recruiting NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Recruiting NCT06069102 - Optimal Blood Pressure Treatment Thresholds Postpartum Phase 4
Recruiting NCT05659173 - Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
Not yet recruiting NCT06281665 - Treatment With Aspirin After Preeclampsia: TAP Trial Phase 4
Completed NCT05124327 - Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy N/A
Recruiting NCT06362356 - Microbial Metabolites and Outcomes of Pregnancy Study
Active, not recruiting NCT04580927 - Breastfeeding and Postpartum Cardiovascular Health N/A
Recruiting NCT05655936 - Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial N/A
Active, not recruiting NCT06019715 - Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy N/A
Not yet recruiting NCT06220721 - Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia Phase 3
Recruiting NCT04989634 - Effects of Dietary and Weight Management on Pregnancy Outcomes in Mobile Medical Platform N/A